Brief: Zyus Life Sciences Finalizing Site Initiation For Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug
22/05/2025 12:09
May 22 (Reuters) - ZYUS Life Sciences Corp ZYUS.V: ZYUS LIFE SCIENCES FINALIZING SITE INITIATION FOR PHASE 2A CLINICAL TRIAL ADVANCING NOVEL NON-OPIOID PAIN DRUG ZYUS LIFE SCIENCES CORP - PATIENT ENROLLMENT FOR UTOPIA-1 EXPECTED TO BEGIN IN JUNE 2025 Source text: ID:nBwRmpZ6a Further company coverage: ZYUS.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zyus Life Sciences
See all newsBrief: Zyus Life Sciences Announces Strategic Realignment To Prioritize Drug Development
Brief: Zyus Life Sciences Reports Preliminary Results From Ongoing Phase 2A Utopia-1 Trial
Brief: ZYUS Life Sciences Provides Update On Clinical Trial Progress And Unit Private Placement
Brief: Zyus Closes First Tranche Of Unit Offering, Issues Warrants Under Loan Agreements And Note Amendment
Brief: Zyus Life Sciences Corporation Announces Closing Of Additional Secured Loan